Australia's largest stock trading and investment forum Australia's #1 stock forum

OSL

Click for more information

12.5%

0.5¢ oncosil medical ltd

TTWhy was this study not done 10 years ago like you suggest? Why...

First 7 Last

Share
Profile

Follow
Gekkowolf

2,302 Posts.

230

12/04/24

10:27

Post #: 73310024
Share

Originally posted by tinyteddy: ↑

The Tripp study will extend the approved use to patients on folfirinox which is the commonest chemo used in pancreatic ca. So that will increase eligibility.
It will also add to the effectiveness dossier for government reimbursement because it’s an RCT so the prospect of public funding becomes much more likely.
This is the study the company should have done 10 years ago.
Gets the product being used in hospitals which irons out process, leads to word of mouth, case presentations etc
Also some patients randomised to placebo might pull out and pay.

Expand

TT

Why was this study not done 10 years ago like you suggest? Why was there no RCT study if it’s the so called gold standard for public reimbursement? Is there any explanation provided?

OSL Price at posting: 0.6¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 13 more messages in this thread...

First 7 Last

Add OSL (ASX) to my watchlist

(20min delay)
Last 0.5¢		Change 0.001(12.5%)		Mkt cap ! $13.39M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.5¢	$16.63K	3.586M

Buyers (Bids)

No.	Vol.	Price($)
46	24064799	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	23289449	12

View Market Depth

No.	Vol.	Price($)
45	23914799	0.004
15	12886597	0.003
5	3757526	0.002
4	7600000	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	23289449	12
0.006	13689997	12
0.007	23036462	21
0.008	2247500	6
0.009	1417500	3

Last trade - 14.07pm 03/05/2024 (20 minute delay)


Last 0.5¢			Change 0.001 ( 10.0 %)
Open	High		Low	Volume
0.5¢	0.5¢		0.5¢	560000
Last updated 14.39pm 03/05/2024 ?

OSL (ASX) Chart